Huber, G. F.
Hüllner, M.
Schmid, C.
Brunner, A.
Sah, B.
Vetter, D.
Kaufmann, P. A.
von Schulthess, G. K.
Article History
Received: 15 August 2017
Revised: 8 November 2017
Accepted: 9 November 2017
First Online: 25 January 2018
Compliance with ethical standards
: FCh-PET in patients with HPT is an approved clinical imaging procedure in our country, and is therefore partly reimbursed by health insurance. Permission for conducting our study was obtained by the ethical committee responsible for our hospital (no. 2016-01616). Due to the retrospective nature of our study, written general informed consent of patients was deemed sufficient by the institutional review board for inclusion into the study. Patients who refused to give signed informed consent were not included into the study. All co-authors mentioned above disclose no potential conflicts of interest.
: The scientific guarantor of this publication is Gerhard Huber.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional review board approval was obtained.
: • prospective• observational• performed at one institution